Latest revision as of 19:22, 22 March 2021

Abstract

Road Traffic Crashes (RTCs) are the third highest cause of death in Zambia, claiming about 2000 lives annually, with pedestrians and cyclists being the most vulnerable. Human error accounts for 87.3% of RTCs. Minibus and big bus public service vehicles (PSVs) are among the common vehicle types involved in these crashes. Given the alarmingly high rate of road traffic crashes involving PSV minibuses and big buses within Zambia, there is a need to mitigate this through innovative solutions. In other settings, it has been shown that stickers in PSVs encouraging passengers to speak out against reckless driving can reduce RTCs, but it is unclear whether such an intervention could work in Zambia. Based on this evidence, the Zambia Road Transport and Safety Agency (RTSA) has developed a road safety bus sticker campaign for PSVs and before national scale-up, RTSA is interested in evidence of the impact of these stickers. This evaluation will be a stratified two-arm randomized controlled trial with a one-to-one ratio. The sample will be stratified by vehicle type, thus creating a two-arm trial for minibuses and a separate two-arm trial for big buses. The sample will include 2110 minibuses and 300 big buses from four towns in Zambia. The primary outcome of interest will be the difference in the rate of RTCs over a 14-month period (7-months before the intervention and 7 months after) between buses with and without the new RTSA road safety bus stickers. This study will provide evidence on the impact of the Zambian sticker program on road traffic crashes as implemented through minibuses and big buses, that can help inform the scale up of a national ‘Zambia road safety bus sticker campaign’. PACT-R, PACTR201711002758216 . Registered 13 November 2017-Retrospectively registered.

Document type: Article

Full document

Original document

The different versions of the original document can be found in:

• http://dx.doi.org/10.1186/s12889-018-5780-3 under the license http://creativecommons.org/licenses/by/4.0/

• http://europepmc.org/articles/PMC6043959 under the license http://creativecommons.org/licenses/by/4.0

• https://bmcpublichealth.biomedcentral.com/track/pdf/10.1186/s12889-018-5780-3

• https://dx.doi.org/10.1186/s12889-018-5780-3 under the license cc-by

• http://link.springer.com/article/10.1186/s12889-018-5780-3,

https://doaj.org/toc/1471-2458

• http://link.springer.com/content/pdf/10.1186/s12889-018-5780-3.pdf,

http://link.springer.com/article/10.1186/s12889-018-5780-3/fulltext.html,

http://dx.doi.org/10.1186/s12889-018-5780-3

• https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-018-5780-3,

https://bmcpublichealth.biomedcentral.com/track/pdf/10.1186/s12889-018-5780-3,

https://link.springer.com/article/10.1186/s12889-018-5780-3,

https://link.springer.com/content/pdf/10.1186%2Fs12889-018-5780-3.pdf,

https://academic.microsoft.com/#/detail/2883365088 under the license http://creativecommons.org/licenses/by/4.0/